IMPLANET announced the signing of an agreement defining the principles of a strategic, technological and financial partnership project with Sanyou Medical, a Chinese manufacturer of medical devices for spine surgery. This is also a technological partnership. The two companies will draw on their know-how and R&D to develop a brand-new comprehensive hybrid fixation range and incorporating the very latest developments and innovations in the field of spine surgery (deformation treatment system, minimally invasive range, robotics, artificial intelligence, etc.).
Shanghai Sanyou Medical Co., Ltd
Equities
688085
CNE1000040J7
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.22 CNY | +0.46% | -5.88% | -21.95% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.95% | 521M | |
+70.88% | 12.06B | |
-11.27% | 8.76B | |
+25.29% | 7.64B | |
-3.97% | 5.56B | |
-7.58% | 4.87B | |
-1.45% | 4.62B | |
+8.48% | 3.94B | |
-26.09% | 2.75B | |
+5.32% | 2.11B |
- Stock
- Equities
- Stock Shanghai Sanyou Medical Co., Ltd - Shanghai S.E.
- News Shanghai Sanyou Medical Co., Ltd
- Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical